{
  "actions": [
    {
      "acted_at": "2003-06-10",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2003-06-10",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    },
    {
      "acted_at": "2003-06-11",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REPORTED",
      "text": "Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.",
      "type": "ordered-reported"
    }
  ],
  "amendments": [],
  "bill_id": "s1225-108",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "markup",
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "108",
  "cosponsors": [
    {
      "bioguide_id": "K000105",
      "district": null,
      "name": "Kennedy, Edward M.",
      "original_cosponsor": true,
      "sponsored_at": "2003-06-10",
      "state": "MA",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M000303",
      "district": null,
      "name": "McCain, John",
      "original_cosponsor": true,
      "sponsored_at": "2003-06-10",
      "state": "AZ",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001141",
      "district": null,
      "name": "Miller, Zell",
      "original_cosponsor": false,
      "sponsored_at": "2003-06-23",
      "state": "GA",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S000148",
      "district": null,
      "name": "Schumer, Charles E.",
      "original_cosponsor": true,
      "sponsored_at": "2003-06-10",
      "state": "NY",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": true,
    "active_at": "2003-06-11",
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2003-06-10",
  "number": "1225",
  "official_title": "A bill entitled the \"Greater Access to Affordable Pharmaceuticals Act\".",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr2491-108",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "Greater Access to Affordable Pharmaceuticals Act",
  "sponsor": {
    "bioguide_id": "G000445",
    "district": null,
    "name": "Gregg, Judd",
    "state": "NH",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REPORTED",
  "status_at": "2003-06-11",
  "subjects": [
    "Administrative procedure",
    "Administrative remedies",
    "Antitrust law",
    "Civil actions and liability",
    "Commerce",
    "Consent decrees",
    "Department of Health and Human Services",
    "Drug approvals",
    "Drug industry",
    "Drugs",
    "Generic drugs",
    "Government Operations and Politics",
    "Health",
    "Intellectual property",
    "Law",
    "Marketing",
    "Patent infringement",
    "Patents",
    "Pharmaceutical research",
    "Punitive damages",
    "Restrictive trade practices",
    "Science, Technology, Communications"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2003-06-10",
    "date": "2003-10-17T21:50:05Z",
    "text": "Greater Access to Affordable Pharmaceuticals Act - Amends the Federal Food, Drug, and Cosmetic Act to: (1) limit a brand name drug manufacturer to one Food and Drug Administration (FDA) 30-month stay of competition in a patent infringement suit against a generic drug applicant; (2) permit a generic applicant being sued to file a counterclaim to correct or delete patent information; (3) limit damages that a brand name manufacturer may recover in an instance where such manufacturer failed to file certain patent information; (4) permit a generic drug applicant to seek declaratory judgment regarding patent infringement prior to marketing a drug; (5) forfeit the180-day market exclusivity period for a first generic drug applicant to a subsequent generic applicant if the first applicant engages in certain activities which impede such drug's timely marketing; and (6) permit alternative means to determine bioequivalence for drugs that are not absorbed into the bloodstream."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Greater Access to Affordable Pharmaceuticals Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill entitled the \"Greater Access to Affordable Pharmaceuticals Act\".",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Greater Access to Affordable Pharmaceuticals Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-15T16:48:44Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/108/s/BILLSTATUS-108s1225.xml"
}